Paroxysmal dystonia and psychotic exacerbations in chronic psychosis: Diagnostic dilemmas and preliminary treatment approaches

• Published in: British journal of clinical pharmacology Vol. 89; no. 9; pp. 2926 - 2932
• Main Authors: Mishra, Biswa Ranjan, Biswas, Tathagata, Sreeraj, Vanteemar S., Nath, Santanu, Mohapatra, Debadatta, Maiti, Rituparna
• Format: Journal Article
• Language: English
• Published: England 01.09.2023
• Subjects: antipsychotic; dopamine; dystonia; GABA; schizophrenia; GABA; antipsychotic; schizophrenia; dopamine; dystonia
• ISSN: 0306-5251; 1365-2125
• DOI: 10.1111/bcp.15777

Patients with chronic psychosis on prolonged antipsychotic therapy may present with paroxysmal dystonia along with an exacerbation of their psychotic symptoms: paroxysmal dystonia and psychotic exacerbations (PDPE). The interindividual variability in the clinical presentations of PDPE can pose challenges in its diagnosis and treatment. The objectives of this work are to (i) discuss this rare phenomenon through a series of 10 patients and a relevant literature review, (ii) conceptualize its neurobiological underpinnings, and (iii) explore the preliminary treatment approaches for its management. Acute stress and/or a dysfunctional gamma‐aminobutyric acid (GABA) ergic or dopaminergic system may be implicated in the pathogenesis of PDPE. The episodes respond acutely to parenteral benzodiazepines, while long‐term management can be achieved by reducing antipsychotic doses, switching to clozapine or using central GABA enhancers. This article is the first attempt at conceptualizing and exploring treatment options for the rare condition PDPE and intends to guide future research in this regard.